You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Receptors, Fibroblast Growth Factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)

Not yet recruiting
  • Urinary Bladder Neoplasms
  • Receptors, Fibroblast Growth Factor
  • Erdafitinib Intravesical Delivery System
  • Kanagawa, Japan
  • +3 more
Jan 27, 2023

Serum Fibroblast Growth Factor-21 Levels During Prolonged

Completed
  • Fibroblast Growth Factor-21
  • Fasting
  • 12 hour fasting for 29 days
  • Ankara, Turkey
    Hacettepe University Nutrition and Dietetics Department
Mar 29, 2023

Fibroblast Growth Factor 21, Tast Perference Trial (Fibroblast growth factor 21 infusion, Placebo infusion (saline))

Active, not recruiting
  • Fibroblast Growth Factor 21
  • Tast Perference
  • Fibroblast growth factor 21 infusion
  • Placebo infusion (saline)
  • Hellerup, Denmark
    Amalie R Lanng
Nov 21, 2022

Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)

Not yet recruiting
  • Fibrous Dysplasia Of Bone
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Fibroblast Growth Factor 23 and Sclerostin in Relation to

Not yet recruiting
  • COVID-19
  • Calcium
  • +3 more
  • Aswan, Egypt
    Aswan University hospital
Mar 11, 2022

NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)

Completed
  • NAFLD
  • Soy isoflavone
  • Placebo
  • Ahvaz, Khuzestan, Iran, Islamic Republic of
    Asal Neshatbini Tehrani
Oct 24, 2023

Healthy Trial in Frederiksberg (Sucrose, Sucrose + protein, Sucrose + fat)

Completed
  • Healthy
  • Sucrose
  • +2 more
  • Frederiksberg, Denmark
    Department of Nutrition, Exercise and Sports, University of Cope
Mar 30, 2022

Fibroblast Growth Factor 23 in Chronic Respiratory Failure

Not yet recruiting
  • Chronic Respiratory Failure
  • Dosage
  • Cardiac echography
  • (no location specified)
Feb 17, 2022

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Beijing, China
  • +5 more
Jan 31, 2023

Gestational Diabetes Trial in ChiangMai (blood draw)

Active, not recruiting
  • Gestational Diabetes
  • blood draw
  • ChiangMai, Thailand
    Maharaj Nakorn ChiangMai Hospital
Dec 1, 2022

Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

Withdrawn
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • (no location specified)
Aug 8, 2022

Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

Recruiting
  • Locally Advanced Gastrointestinal Stromal Tumor
  • +7 more
  • Biopsy
  • +4 more
  • Duarte, California
  • +17 more
Feb 2, 2023

Fibroblast Growth Factor 23 and Hypertensive Disorder

Recruiting
  • Hypertension, Pregnancy-Induced
    • Guangzhou, Guangdong, China
      Obstetrics and Gynechology Department of the 1st affiliated hosp
    Sep 5, 2021

    Fasting Trial in Boston (oral carbohydrate challenge)

    Active, not recruiting
    • Fasting
    • oral carbohydrate challenge
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jul 18, 2022

    Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba

    Active, not recruiting
    • Fibroblast Growth Factor 23
    • +2 more
      • Córdoba, Spain
        Hospital Universitario Reina Sofia
      Apr 27, 2022

      Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

      Recruiting
      • Urothelial Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 8, 2023

      Chronic Kidney Disease Trial in Montpellier, Saint-Jean-de-Védas (Plasma osteoprotegerin level, Plasma fibroblast growth factor

      Recruiting
      • Chronic Kidney Disease
      • Plasma osteoprotegerin level
      • +2 more
      • Montpellier, France
      • +6 more
      Dec 31, 2021

      Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

      Terminated
      Has Results
      • Bladder Cancer
      • Indianapolis, Indiana
      • +2 more
      Jul 7, 2022

      Nonalcoholic Steatohepatitis Trial in Glendale (B1344, Placebo)

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Glendale, California
        California Clinical Trials Medical Group, Inc.
      Dec 8, 2022

      Tympanic Membrane Perforation Trial in Boston, Lackland Air Force Base (FGF-2, Placebo)

      Completed
      Has Results
      • Tympanic Membrane Perforation
      • Boston, Massachusetts
      • +1 more
      Dec 7, 2020

      Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Phoenix, Arizona
      • +36 more
      Jan 27, 2023

      Chronic Kidney Disease Trial in France (Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular

      Recruiting
      • Chronic Kidney Disease
      • Plasma osteoprotegerin level
      • +2 more
      • Castelnau Le Lez, France
      • +4 more
      Apr 13, 2022

      Squamous-cell NSCLC Trial in Switzerland (Rogaratinib)

      Active, not recruiting
      • Squamous-cell Non-small Cell Lung Cancer
      • Baden, Switzerland
      • +10 more
      Jan 20, 2022

      Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)

      Recruiting
      • Advanced or Recurrent Solid Tumors
      • FGFR Gene Alterations
      • Aoba-ku, Sendai, Miyagi, Japan
      • +4 more
      May 9, 2022

      FGF23 as a Marker of Acute Kidney Injury

      Recruiting
      • Acute Kidney Injury
      • Kidney Ischemia
      • Plasmatic Fibroblast Growth Factor-23 by means of ELISA
      • Santiago, Chile
        Hospital Clinic Universidad de Chile
      Dec 30, 2020